Brief: GlaxoSmithKline’s 2017 Q1 Result

GlaxoSmithKline today released Unaudited  Interim Financial Statements for the three months ended 31 March 2017.   Revenue N’million Q1 2017| N3,850 Also Read Iyinoluwa Aboyeji exits Learn Africa board after six yearsOPay reaffirms long-term commitment to NigeriaRoyal Exchange appoints Geoffrey Ohen as Non-Executive Director Q1 2016| N4,152 %age change|-7%   (Loss)/Profit after tax  N’million Q1 […]